Hakki, T., K. Hübel, H. Waldmann and R. Bernhardt: The development of a whole-cell based medium throughput screening system for the discovery of human aldosterone synthase (CYP11B2) inhibitors: Old drugs disclose new applications for the therapy of congestive heart failure, myocardial fibrosis and hypertension. In: Journal of Steroid Biochemistry and Molecular Biology 125, 120-128, Seq. No.: 1 (2011).
url: http://dx.doi.org/10.1016/j.jsbmb.2010.12.011
Bleif, S., F. Hannemann, M. Lisurek, J.P. von Kries, J. Zapp, M. Dietzen, I. Antes and R. Bernhardt: Identification of CYP106A2 as a Regioselective Allylic Bacterial Diterpene Hydroxylase. In: ChemBioChem 12, 4, 576-582 (2011).
doi: 10.1002/cbic.201000404
url: http://dx.doi.org/10.1002/cbic.201000404
localid: C125673F004B2D7B-2E95E033A7C7862EC1257831004AD54C-Dietzen2011
Lisurek, M., B. Simgen, I. Antes and R. Bernhardt: Theoretical and Experimental Evaluation of a CYP106A2 Low Homology Model and Production of Mutants with Changed Activity and Selectivity of Hydroxylation. In: ChemBioChem 9, 9, 1439-1449 (2008).
doi: 10.1002/cbic.200700670
url: http://dx.doi.org/10.1002/cbic.200700670
localid: C125756E0038A185-0F431653A2900B9DC125757C002E7B38-Lisurek2008
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.